Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2015 2
2016 1
2018 1
2019 3
2020 4
2021 2
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
What did we learn in 35 years of research on nutrition and supplements for age-related macular degeneration: a systematic review.
Pameijer EM, Heus P, Damen JAA, Spijker R, Hooft L, Ringens PJ, Imhof SM, van Leeuwen R. Pameijer EM, et al. Acta Ophthalmol. 2022 Dec;100(8):e1541-e1552. doi: 10.1111/aos.15191. Epub 2022 Jun 13. Acta Ophthalmol. 2022. PMID: 35695158 Free PMC article. Review.
The aim of this paper is to summarize all available evidence from systematic reviews, randomized controlled trials (RCTs) and comparative nonrandomized studies (NRS) on the association between nutrition and antioxidant, vitamin, and mineral supplements and the development or prog …
The aim of this paper is to summarize all available evidence from systematic reviews, randomized controlled trials (RCTs) and comparative no …
Geographic distributions of age-related macular degeneration incidence: a systematic review and meta-analysis.
Zhou M, Duan PC, Liang JH, Zhang XF, Pan CW. Zhou M, et al. Br J Ophthalmol. 2021 Oct;105(10):1427-1434. doi: 10.1136/bjophthalmol-2020-316820. Epub 2020 Sep 9. Br J Ophthalmol. 2021. PMID: 32907810
PURPOSE: We performed a systematic review and meta-analysis to summarise the geographic distribution of age-related macular degeneration (AMD) incidence. METHODS: Databases including PubMed, Embase and Web of Science were searched for publications of early and late …
PURPOSE: We performed a systematic review and meta-analysis to summarise the geographic distribution of age-related macular degene …
Systemic levels of interleukin-6 in patients with age-related macular degeneration: a systematic review and meta-analysis.
Nahavandipour A, Krogh Nielsen M, Sørensen TL, Subhi Y. Nahavandipour A, et al. Acta Ophthalmol. 2020 Aug;98(5):434-444. doi: 10.1111/aos.14402. Epub 2020 Mar 16. Acta Ophthalmol. 2020. PMID: 32180348 Free article. Review.
Age-related macular degeneration (AMD) is the most prevalent cause of irreversible vision loss in industrialized countries. ...In this study, we systemically reviewed the literature to provide an overview of the field and used meta-analyses to provide a summa …
Age-related macular degeneration (AMD) is the most prevalent cause of irreversible vision loss in industrialized countries. .. …
Prevalence of Charles Bonnet syndrome in patients with age-related macular degeneration: systematic review and meta-analysis.
Niazi S, Krogh Nielsen M, Singh A, Sørensen TL, Subhi Y. Niazi S, et al. Acta Ophthalmol. 2020 Mar;98(2):121-131. doi: 10.1111/aos.14287. Epub 2019 Oct 26. Acta Ophthalmol. 2020. PMID: 31654492 Free article.
Age-related macular degeneration (AMD) is the most common cause of visual impairment in the developed world. A number of patients experience complex lifelike visual experiences-Charles Bonnet syndrome (CBS). In this systematic review, our aim was to provide an ov …
Age-related macular degeneration (AMD) is the most common cause of visual impairment in the developed world. A number of patie …
Overview of Systematic Reviews and Meta-analyses on Systemic Adverse Events Associated With Intravitreal Anti-Vascular Endothelial Growth Factor Medication Use.
Thulliez M, Angoulvant D, Pisella PJ, Bejan-Angoulvant T. Thulliez M, et al. JAMA Ophthalmol. 2018 May 1;136(5):557-566. doi: 10.1001/jamaophthalmol.2018.0002. JAMA Ophthalmol. 2018. PMID: 29566105
IMPORTANCE: The systemic safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications is still a matter of debate. OBJECTIVE: This overview of systematic reviews evaluates systemic adverse events associated with intravitreal anti-VEGF treatments i …
IMPORTANCE: The systemic safety of intravitreal anti-vascular endothelial growth factor (anti-VEGF) medications is still a matter of debate. …
Artificial intelligence in screening, diagnosis, and classification of diabetic macular edema: A systematic review.
Shahriari MH, Sabbaghi H, Asadi F, Hosseini A, Khorrami Z. Shahriari MH, et al. Surv Ophthalmol. 2023 Jan-Feb;68(1):42-53. doi: 10.1016/j.survophthal.2022.08.004. Epub 2022 Aug 12. Surv Ophthalmol. 2023. PMID: 35970233 Review.
We review the application of artificial intelligence (AI) techniques in the screening, diagnosis, and classification of diabetic macular edema (DME) by searching six databases- PubMed, Scopus, Web of Science, Science Direct, IEEE, and ACM- from January 1, 2005 to July 4, 2 …
We review the application of artificial intelligence (AI) techniques in the screening, diagnosis, and classification of diabetic macular …
Eye disorders other than diabetic retinopathy in patients with diabetes.
Feldman-Billard S, Dupas B. Feldman-Billard S, et al. Diabetes Metab. 2021 Nov;47(6):101279. doi: 10.1016/j.diabet.2021.101279. Epub 2021 Sep 14. Diabetes Metab. 2021. PMID: 34534696 Review.
AIM: While diabetic retinopathy is the most specific complication of chronic hyperglycaemia, numerous other ocular conditions also can involve the eyes of people with diabetes. Cataract, glaucoma, age-related macular degeneration, retinal vascular occlusion, and acu …
AIM: While diabetic retinopathy is the most specific complication of chronic hyperglycaemia, numerous other ocular conditions also can invol …
How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
Empeslidis T, Storey M, Giannopoulos T, Konidaris V, Tranos PG, Panagiotou ES, Voudouragkaki IC, Konstas AG. Empeslidis T, et al. Adv Ther. 2019 Jul;36(7):1532-1548. doi: 10.1007/s12325-019-00971-0. Epub 2019 May 17. Adv Ther. 2019. PMID: 31102206 Free PMC article.
Emerging anti-vascular endothelial growth factor (anti-VEGF) therapies for neovascular age-related macular degeneration (nAMD) have revolutionised medical retina practice and the management and eventual outcome of nAMD. ...
Emerging anti-vascular endothelial growth factor (anti-VEGF) therapies for neovascular age-related macular degeneration (nAMD) …
Systemic levels of C-reactive protein in patients with age-related macular degeneration: A systematic review with meta-analyses.
Feng C, Krogh Nielsen M, Sørensen TL, Subhi Y. Feng C, et al. Mech Ageing Dev. 2020 Oct;191:111353. doi: 10.1016/j.mad.2020.111353. Epub 2020 Sep 13. Mech Ageing Dev. 2020. PMID: 32937187
However, in some individuals this process is exacerbated and causes development of age-related macular degeneration. Late features of age-related macular degeneration include geographic atrophy of the neuroretina or choroidal neovascularization. ...Our …
However, in some individuals this process is exacerbated and causes development of age-related macular degeneration. Late feat …
[Stem cell therapy for retinal diseases].
Balmer J, Stanzel BV, Fischer MD. Balmer J, et al. Ophthalmologe. 2015 Sep;112(9):728-37. doi: 10.1007/s00347-015-0119-2. Ophthalmologe. 2015. PMID: 26271739 Review. German.
OBJECTIVES: To introduce readers to the terminology and current concepts associated with stem cell therapy in ocular research and to provide an overview of the current status of preclinical and clinical research. ...
OBJECTIVES: To introduce readers to the terminology and current concepts associated with stem cell therapy in ocular research and to provide …
15 results